Company

Sydnexis

Pharmaceutical Manufacturing Del Mar, California, United States 21 employees

Employees: 21
Contacts: 3
Emails: 3
Phones: 1

www.sydnexis.com LinkedIn

Sydnexis Overview

Headquarters: Del Mar, California, United States
Website: www.sydnexis.com
Industry: Pharmaceutical Manufacturing
Employees: 21
Founded: 2014
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About Sydnexis

Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence over the last 30 years. Once considered a benign refractive condition, even at low levels, myopia is now associated with many serious ophthalmic co- morbidities. The greater myopia severity, the higher the risk of these ophthalmic co-morbidities later in life. Sydnexis was founded with the goal of developing a proprietary, stable, low-dose atropine eyedrop to treat myopia progression in children and minimize the risk of ocular co-morbidities. At Sydnexis, we have focused on developing a best-in-class low-dose atropine formulation to address the juvenile-onset myopia pandemic.

Sydnexis Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Sydnexis Org Chart

Sample employees and titles

Name	Title	Location	Contact
Anna Haskell	Founder - Angel Investor - Principal		View
Ben Liniger	Strategic National Account Director │ Corporate │ Market Access Executive │ Launch Strategy Expert	Owasso, Oklahoma, United States	Email
Perry J. Sternberg		Mountain Lakes, New Jersey, United States	Email Phone
Zach Scheiner		San Francisco Bay Area, United States	Email